Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

S&P Biotech SPDR (XBI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fund basics

See More

Price Performance

See More
Period Period Low Period High Performance
1-Month
66.66 +19.61%
on 05/31/17
80.25 -0.65%
on 06/22/17
+10.08 (+14.47%)
since 05/23/17
3-Month
66.00 +20.80%
on 04/06/17
80.25 -0.65%
on 06/22/17
+11.57 (+16.97%)
since 03/23/17
52-Week
49.51 +61.04%
on 06/27/16
80.25 -0.65%
on 06/22/17
+25.21 (+46.24%)
since 06/23/16

Most Recent Stories

More News
Republicans Present Healthcare Bill: Top 5 Gainers

Healthcare stocks posted record highs, with hospitals and insurers climbing after Senate Republicans released a draft bill to replace Obamacare.

XPH : 43.81 (+0.02%)
LNTH : 14.85 (-1.66%)
MOH : 71.44 (+0.18%)
HCA : 85.83 (-0.36%)
AEL : 24.87 (+0.61%)
HIIQ : 25.52 (+5.24%)
ANTM : 190.61 (-1.42%)
CNC : 83.91 (+1.10%)
XBI : 79.58 (+0.48%)
THC : 18.47 (-2.28%)
CBM : 60.35 (-0.90%)
5 Reasons Why Biotech ETFs are Soaring

Reasons that propelled the biotech space and the related ETFs higher.

BBP : 41.12 (-0.17%)
BBC : 24.69 (+0.78%)
UBIO : 34.79 (-1.08%)
IBB : 318.62 (-0.47%)
BBH : 129.39 (-0.70%)
CLVS : 93.31 (-3.59%)
BIB : 56.55 (-0.82%)
LABU : 69.87 (+1.66%)
XBI : 79.58 (+0.48%)
The New Biotech Boom Begins NOW

This post The New Biotech Boom Begins NOW appeared first on Daily Reckoning . Biotech is blowing every other sector out of the water this week. The biotech sector tossed the flagging Nasdaq over its...

XLE : 64.14 (+0.30%)
XBI : 79.58 (+0.48%)
Biotech Industry Showing Signs of a Revival in 2017: Today's Research on Moleculin Biotech and Merrimack Pharmaceuticals

NEW YORK, NY / ACCESSWIRE / June 22, 2017 / The Biotech Industry has continued to outperform the broader markets in 2017. Biotech companies appear to be benefitting from a speedier FDA approval process...

XBI : 79.58 (+0.48%)
MBRX : 1.08 (+6.94%)
MACK : 1.36 (-6.85%)
5 Reasons Why Biotech ETFs are Soaring

Reasons that propelled the biotech space and the related ETFs higher.

BBP : 41.12 (-0.17%)
BBC : 24.69 (+0.78%)
UBIO : 34.79 (-1.08%)
IBB : 318.62 (-0.47%)
BBH : 129.39 (-0.70%)
CLVS : 93.31 (-3.59%)
BIB : 56.55 (-0.82%)
LABU : 69.87 (+1.66%)
XBI : 79.58 (+0.48%)
4 Stocks & ETFs to Buy on Clovis' Positive Drug Data

Clovis Oncology clinical trial data has given a boost to the biotech sector and put these stocks and ETFs in focus.

BBC : 24.69 (+0.78%)
CLDX : 2.61 (+1.16%)
CNCR : 23.35 (-0.30%)
IBB : 318.62 (-0.47%)
LABU : 69.87 (+1.66%)
KITE : 97.98 (+4.25%)
CGIX : 3.82 (+0.47%)
BBP : 41.12 (-0.17%)
SBIO : 28.35 (+0.78%)
UBIO : 34.79 (-1.08%)
INCY : 136.02 (+0.29%)
CLVS : 93.31 (-3.59%)
BIB : 56.55 (-0.82%)
XBI : 79.58 (+0.48%)
Biotech Industry Showing Signs of a Revival in 2017: Today's Research on GW Pharmaceuticals and ZIOPHARM Oncology

NEW YORK, NY / ACCESSWIRE / June 21, 2017 / The Biotech Industry has continued to outperform the broader markets in 2017. Biotech companies appear to be benefitting from a speedier FDA approval process...

GWPH : 102.92 (+0.01%)
ZIOP : 6.19 (+1.98%)
XBI : 79.58 (+0.48%)
Biotech Industry Showing Signs of a Revival in 2017: Today's Research on Lipocine and Portola Pharmaceuticals

NEW YORK, NY / ACCESSWIRE / June 21, 2017 / The Biotech Industry has continued to outperform the broader markets in 2017. Biotech companies appear to be benefitting from a speedier FDA approval process...

LPCN : 4.21 (-2.55%)
PTLA : 54.17 (+41.62%)
XBI : 79.58 (+0.48%)
Biotech Industry Showing Signs of a Revival in 2017: Today's Research on Gilead Sciences and Sarepta Therapeutics

NEW YORK, NY / ACCESSWIRE / June 21, 2017 / The Biotech Industry has continued to outperform the broader markets in 2017. Biotech companies appear to be benefitting from a speedier FDA approval process...

SRPT : 34.74 (-2.09%)
GILD : 69.98 (-0.71%)
XBI : 79.58 (+0.48%)
4 Stocks & ETFs to Buy on Clovis' Positive Drug Data

Clovis Oncology clinical trial data has given a boost to the biotech sector and put these stocks and ETFs in focus.

BBC : 24.69 (+0.78%)
CLDX : 2.61 (+1.16%)
CNCR : 23.35 (-0.30%)
IBB : 318.62 (-0.47%)
LABU : 69.87 (+1.66%)
KITE : 97.98 (+4.25%)
CGIX : 3.82 (+0.47%)
BBP : 41.12 (-0.17%)
SBIO : 28.35 (+0.78%)
UBIO : 34.79 (-1.08%)
INCY : 136.02 (+0.29%)
CLVS : 93.31 (-3.59%)
BIB : 56.55 (-0.82%)
XBI : 79.58 (+0.48%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is in the Top 1%. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More

Fund Summary

The SPDR SP Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Biotechnology Select Industry Index.

See More

Support & Resistance

2nd Resistance Point 81.25
1st Resistance Point 80.22
Last Price 79.59
1st Support Level 78.20
2nd Support Level 77.21

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.